Reduced expression of PTEN and increased PTEN phosphorylation at residue Ser380 in gastric cancer tissues: A novel mechanism of PTEN inactivation

Clinics and Research in Hepatology and Gastroenterology

Volumn 37, Issue 1, 2013, Pages 72-79

  Yang, Zhen ^a   Yuan, Xiao Gang ^a   Chen, Jiang ^a   Luo, Shi Wen ^a   Luo, Zhi Jun ^b   Lu, Nong Hua ^a  

^a NANCHANG UNIVERSITY   (China)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CHRONIC GASTRITIS; DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STOMACH CANCER; STOMACH MUCOSA; WESTERN BLOTTING;

FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHORYLATION; PTEN PHOSPHOHYDROLASE; STOMACH NEOPLASMS;

EID: 84873123369     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2012.03.002     Document Type: Article

References (23)

1. Garcia M, Jemal A, Ward EM, Center MM, Hao Y, Siegel RL, et al. Global cancer facts & figures 2007. Atlanta, GA: American cancer society, 2007.
2. Parkin D.M. International variation. Oncogene 2004, 23:6329-6340.
3. Jemal A., Siegal R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
4. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997, 275:1943-1947.
5. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K., Lin H., Ligon A.H., et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23. 3 that is mutated in multiple advanced cancers. Nat Genet 1997, 15:356-362.
6. Li D.M., Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997, 57:2124-2129.
7. Tamura M., Gu J., Takino T., Yamada K.M. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. Cancer Res 1999, 59:442-449.
8. Stambolic V., Suzuki A., de la Pompa J.L., Brothers G.M., Mirtsos C., Sasaki T., et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998, 95:29-39.
9. Gu J., Tamura M., Yamada K.M. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol 1998, 143:1375-1383.
10. Tamura M., Gu J., Matsumoto K., Aota S., Parsons R., Yamada K.M. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 1998, 280:1614-1617.
11. Sansal I., Sellers W.R. The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 2004, 22:2954-2963.
12. Wang J.Y., Huang T.J., Chen F.M., Hsieh M.C., Lin S.R., Hou M.F., et al. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas. Virchows Arch 2003, 442:437-443.
13. Byun D.S., Cho K., Ryu B.K., Lee M.G., Park J.I., Chae K.S., et al. Frequent monoallelic deletion of PTEN and its reciprocal association with PIK3CA amplification in gastric carcinoma. Int J Cancer 2003, 104:318-327.
14. Li Y.L., Tian Z., Wu D.Y., Fu B.Y., Xin Y. Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions. World J Gastroenterol 2005, 11:285-288.
15. Kang Y.H., Lee H.S., Kim W.H. Promoter methylation and silencing of PTEN in gastric carcinoma. Lab Invest 2002, 82:285-291.
16. Hino R., Uozaki H., Murakami N., Ushiku T., Shinozaki A., Ishikawa S., et al. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res 2009, 69:2766-2774.
17. Vazquez F., Ramaswamy S., Nakamura N., Sellers W.R. Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol 2000, 20:5010-5018.
18. Torres J., Pulido R. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J Biol Chem 2001, 276:993-998.
19. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American cancer society award lecture on cancer epidemiology and prevention. Cancer Res 1992, 52:6735-6740.
20. Hamilton S.R., Aaltonen L.A. Pathology and genetics of tumors of the digestive system. World Health Organization classification of tumors 2000, IARCP, Lyon.
21. Dixon M.F., Genta R.M., Yardley J.H., Correa P. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 1996, 20:1161-1181.
22. Yang L., Kuang L.G., Zheng H.C., Li J.Y., Wu D.Y., Zhang S.M., et al. PTEN encoding product: a marker for tumorigenesis and progression of gastric carcinoma. World J Gastroenterol 2003, 9:35-39.
23. Park G.S., Joo Y.E., Kim H.S., Choi S.K., Rew J.S., Park C.S., et al. Expression of PTEN and its correlation with angiogenesis in gastric carcinoma. Korean J Gastroenterol 2005, 46:196-203.